Extrastriatal dopamine D(2) receptor binding in Huntington's disease

Area of Science:

• Neuroscience
• Radiochemistry
• Medical Imaging

Background:

• Huntington's disease (HD) is a neurodegenerative disorder impacting medium spiny neurons, predominantly in the striatum.
• Reduced striatal dopamine D(2) receptor density is a known feature of HD, but extrastriatal changes remain less understood.

Purpose of the Study:

• To compare dopamine D(2) receptor binding in brain regions outside the striatum between patients with Huntington's disease and age-matched controls.
• To investigate the relationship between striatal dopamine D(2) receptor binding and clinical assessments in HD patients.

Main Methods:

• Utilized high-resolution positron emission tomography (PET) with the radioligand [(11)C]FLB 457 to assess dopamine D(2) receptor binding potential.
• Employed region-of-interest (ROI) based analysis with atrophy correction.
• Applied partial least square regression to analyze binding potential across multiple brain regions.

Main Results:

• Dopamine D(2) receptor binding potential was significantly reduced in the striatum of HD patients compared to controls.
• No significant differences in dopamine D(2) receptor binding were observed in thalamic and cortical subregions between HD patients and controls.
• Striatal binding potential was the primary determinant separating HD patients from controls, and correlated with chorea severity and cognitive performance.

Conclusions:

• Dopamine D(2) receptors outside the striatum are largely preserved in early to mid-stage Huntington's disease.
• This preservation of extrastriatal dopamine D(2) receptors may offer therapeutic implications for managing HD symptoms.